procarbazine and Prostatic Hyperplasia
procarbazine has been researched along with Prostatic Hyperplasia in 1 studies
Procarbazine: An antineoplastic agent used primarily in combination with mechlorethamine, vincristine, and prednisone (the MOPP protocol) in the treatment of Hodgkin's disease.
procarbazine : A benzamide obtained by formal condensation of the carboxy group of 4-[(2-methylhydrazino)methyl]benzoic acid with the amino group of isopropylamine. An antineoplastic chemotherapy drug used for treatment of Hodgkin's lymphoma. Metabolism yields azo-procarbazine and hydrogen peroxide, which results in the breaking of DNA strands.
Prostatic Hyperplasia: Increase in constituent cells in the PROSTATE, leading to enlargement of the organ (hypertrophy) and adverse impact on the lower urinary tract function. This can be caused by increased rate of cell proliferation, reduced rate of cell death, or both.
Research
Studies (1)
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors
Authors | Studies |
---|---|
Varkarakis, MJ | 1 |
Gaeta, JF | 1 |
Mirand, EA | 1 |
Murphy, GP | 1 |
Other Studies
1 other study available for procarbazine and Prostatic Hyperplasia
Article | Year |
---|---|
Morphological responses of benign human prostatic hypertrophic tissue to chemotherapeutic agents in an in vitro culture system.
Topics: Aged; Altretamine; Dacarbazine; Fluorouracil; Humans; Lomustine; Male; Microscopy; Middle Aged; Orga | 1975 |